Table 1 Characteristics of included studies
Study | Participants number | Age Mean (SD) | BMI Mean (SD) | SARSCoV-2 infection number |
|---|---|---|---|---|
Schegl et al. (2020) | Adult AN (n = 112) Adolescent AN (n = 47) | 25.00 (9.16) 16.26 (0.92) | 17.67 (2.55) 18.22 (2.09) | N = 3 N = 0 |
Schegl et al. (2020) | BN (n = 55) | 24.42 (6.36) | 23.62 (4.58) | N = 1 |
Robertson et al. (2021) | Healthy (n = 125) ED (n = 35) Mental health condition (n = 104) (women = 206) | Age range: 18–79 (n = 111) Age range: 18–29 (n = 151) Age range: 30 +  | NA | NA |
Machitelli et al. (2020) | without a Psychiatric Diagnosis (n = 63) (women = 42) with a Psychiatric Diagnosis (n = 47) (women = 36) | 47.24 (14.3) 46.38 (14.5) | 40.19 (6.8) 39.88 (6.8) | NA |
Phillipou et al. (2020) | ED (n = 188) (AN = 88 BN = 23) (women = 179) General population (n = 5289) | 30.47 (8.19) 29.74 (7.25) 40.62 (13.67) | NA | 1 10 |
Branley-Bell et al. (2020) | ED (n = 129) (Currently experiencing an ED = 80 Being in recovery = 49) (women = 121) | 29.27 (8.99) | NA | NA |
Frayn et al. (2021) | BED (n = 11) (women = 7) | 42.8 (14.2) | 34.7 (10.3) | NA |
Vuillier et al. (2021) | AN (n = 91) (women = 7) BN (n = 46) (women = 7) BED (n = 44) (women = 7) OSFED (n = 26) (women = 7) | 30.0 (9.7) 28.7 (9.1) 31.8 (9.2) 32.6 (10.7) | NA | NA |
Termorshuizen et al. (2020) | UN: ED (n = 511) (women = 495) (AN = 318, BN = 178, BED = 156) NL: ED (n = 510) (women = 506) (AN = 347, BN = 117, BED = 60) | UN: 30.61 (9.37) NL: 16–60 +  | NA | UN: 7 NL: 9 |
McCombie et al. (2020) | ED (n = 32) (women = 30) (AN = 23, BN = 3, BED = 1) | 35.3 (10.3) | NA | NA |
Spettigue et al. (2021) | ED-2019 (n = 43) (women = 32) COVID-triggered ED (n = 19) (women = 14) Non COVID-triggered ED (n = 29) (women = 26) | 14.6 (1.79) 14.23 (1.82) 14.84 (1.76) | 18.12 16.74 18.41 | NA |
Spigel et al. (2021) | ED (n = 73) (women = 68) (AN = 62) | 19.1 (3.0) | NA | NA |
Jonikas et al. (2021) | Behavioral health disorders (n = 272) (women = 155) | 50 (13.5) | NA | NA |